Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

References

• Allebeck, P., & Bolund, C. (1991). Suicides and suicide attempts in cancer patients. Psychological Medicine, 21, 979–984. doi:10.1017/S0033291700029962
   PubMed Web of Science ®Google Scholar
• American Cancer Society, Cancer Facts & Figures 2018. Atlanta: American Cancer Society, 2018. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf (Accessed on 3/21/2018).
   Google Scholar
• Bogenschutz, M. P., & Ross, S. (2018). Therapeutic Applications of Classic Hallucinogens. Current Topics in Behavioral Neurosciences, 36, 361–391. doi:10.1007/7854_2016_464.
   PubMedGoogle Scholar
• Breitbart, W., Rosenfeld, B., Pessin, H., Kaim, M., Funesti-Esch, J., Galietta, M., … Brescia, R. (2000). Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA, 284, 2907–2911. doi:10.1001/jama.284.22.2907
   PubMed Web of Science ®Google Scholar
• Breitbart, W., Rosenfeld, B., Gibson, C., Pessin, H., Poppito, S., Nelson, C., … Olden, M. (2010). Meaning-centered group psychotherapy for patients with advanced cancer: A pilot randomized controlled trial. Psychooncology, 19, 21–28. doi:10.1002/pon.1556
   PubMed Web of Science ®Google Scholar
• Brown, K. W., Levy, A. R., Rosberger, Z., & Edgar, L. (2003). Psychological distress and cancer survival: A follow-up 10 years after diagnosis. Psychosomatic Medicine, 65, 636–643. doi:10.1097/01.PSY.0000077503.96903.A6
   PubMed Web of Science ®Google Scholar
• Bultz, B. D., & Holland, J.C. (2006). Emotional distress in patients with cancer: the sixth vital sign. Community Oncology, 3, 311–314. doi:10.1016/S1548-5315(11)70702-1
   Google Scholar
• Davis, J. (2003). An overview of transpersonal psychology. The Humanistic Psychologist, 31, 6–21. doi:10.1080/08873267.2003.9986924
   Google Scholar
• Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., … Bray, F. (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr
   Google Scholar
• Frankl, V. (1984). Man’s search for meaning. New York: Simon & Schuster.
   Google Scholar
• Freedman, R. (2010). Abrupt withdrawal of antidepressant treatment. American Journal of Psychiatry, 167, 886–888. doi:10.1176/appi.ajp.2010.10050783
   PubMed Web of Science ®Google Scholar
• Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. Journal of Nervous and Mental Disease, 202, 513–520. doi:10.1097/NMD.0000000000000113
   PubMed Web of Science ®Google Scholar
• Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29, 57–68. doi:10.1177/0269881114555249
   PubMed Web of Science ®Google Scholar
• Grassi, L., Caruso, R., Hammelef, K., Nanni, M. G., & Riba, M. (2014). Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review. International Review of Psychiatry, 26, 44–62. doi:10.3109/09540261.2013.842542
   PubMed Web of Science ®Google Scholar
• Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G.R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68, 71–78. doi:10.1001/archgenpsychiatry.2010.116
   PubMed Web of Science ®Google Scholar
• Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (1973). LSD-assisted psychotherapy in patients with terminal cancer. International Pharmacopsychiatry, 8, 129–144. doi:10.1159/000467984
   PubMedGoogle Scholar
• Grof, S., & Halifax, J. (1977). The human encounter with death. New York: EP Dutton.
   Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30, 1181–1197. doi:10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl), 187, 268–283. doi:10.1007/s00213-006-0457-5
   PubMed Web of Science ®Google Scholar
• Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology, 22, 621–632. doi:10.1177/0269881108094300
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology (Berl), 218, 649–665. doi:10.1007/s00213-011-2358-5
   PubMed Web of Science ®Google Scholar
• Iovieno, N., Tedeschini, E., Ameral, V. E., Rigatelli, M., & Papakostas, G. I. (2011). Antidepressants for major depressive disorder in patients with co-morbid axis-III disorder: A meta-analyses of patient characteristics and placebo response rates in randomized controlled trials. International Clinical Psychopharmacology, 26, 69–74. doi:10.1097/YIC.0b013e328340775e
   PubMed Web of Science ®Google Scholar
• Johnson, M., Richards, W., & Griffiths, R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology (Oxford), 22, 603–620. doi:10.1177/0269881108093587
   PubMed Web of Science ®Google Scholar
• Kast, E. C., & Collins, V.J. (1964). Study of Lysergic Acid Diethylamide as an Analgesic Agent. Anesthesia & Analgesia, 43, 285–291.
   PubMed Web of Science ®Google Scholar
• Kast, E. (1966). LSD and the dying patient. The Chicago Medical School Quarterly, 26, 80–87.
   PubMedGoogle Scholar
• Kast, E. (1967). Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide. The Psychiatric Quarterly, 41, 646–657. doi:10.1007/BF01575629
   PubMed Web of Science ®Google Scholar
• Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54, 216–226. doi:10.1016/S0006-3223(03)00273-7
   PubMed Web of Science ®Google Scholar
• Kissane, D. W. (2000). Psychospiritual and existential distress. The challenge for palliative care. Australian Family Physician, 29, 1022–1025.
   PubMedGoogle Scholar
• Laoutidis, Z. G., & Mathiak, K. (2013). Antidepressants in the treatment of depression/depressive symptoms in cancer patients: A systematic review and meta-analysis. BMC Psychiatry, 13, 140 doi:10.1186/1471-244X-13-140
   PubMed Web of Science ®Google Scholar
• Lemay, K., & Wilson, K. G. (2008). Treatment of existential distress in life threatening illness: A review of manualized interventions. Clinical Psychology Review, 28, 472–493. doi:10.1016/j.cpr.2007.07.013
   PubMed Web of Science ®Google Scholar
• Levi, F., Bulliard, J. L., & la Vecchia, C. (1991). Suicide risk among incident cases of cancer in the Swiss Canton of Vaud. Oncology, 48, 44–47. doi:10.1159/000226893
   PubMed Web of Science ®Google Scholar
• Li, X., Frye, M. A., & Shelton, R.C. (2012). Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmaco-logy, 37, 77–101. doi:10.1038/npp.2011.198
   PubMed Web of Science ®Google Scholar
• McClain, C. S., Rosenfeld, B., & Breitbart, W. (2003). Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet, 361, 1603–1607. doi:10.1016/S0140-6736(03)13310-7
   PubMed Web of Science ®Google Scholar
• Meier, E. A., Gallegos, J. V., Montross-Thomas, L. P., Depp, C. A., Irwin, S. A., & Jeste, D. V. (2016). Defining a Good Death (Successful Dying): Literature review and a call for research and public dialogue. The American Journal of Geriatric Psychiatry, 24, 261–271. doi:10.1016/j.jagp.2016.01.135
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 12, 160–174. doi:10.1016/S1470-2045(11)70002-X
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, P. (2009). Preferreed reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Medicine, 6, e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Murata, H. (2003). Spiritual pain and its care in patients with terminal cancer: construction of a conceptual framework by philosophical approach. Palliative & Supportive Care, 1, 15–21.
   PubMedGoogle Scholar
• NCCN (National Comprehensive Cancer Network). (2014). Clinical practice guidelines in oncology: distress management (version I.2014). Available at: www.NCCN.org
   Google Scholar
• Nelson, C. J., Rosenfeld, B., Breitbart, W., & Galietta, M. (2002). Spirituality, religion, and depression in the terminally ill. Psychosomatics, 43, 213–220. doi:10.1176/appi.psy.43.3.213
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68, 264–355. doi:10.1124/pr.115.011478
   PubMed Web of Science ®Google Scholar
• Nutt, D. (2016). Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future. Journal of Psychopharmacology (Oxford), 30, 1163–1164. doi:10.1177/0269881116675754
   PubMed Web of Science ®Google Scholar
• Ostuzzi, G., Matcham, F., Dauchy, S., & Barbui, C. (2015). Antidepressants for the treatment of depression in people with cancer. The Cochrane Database of Systematic Reviews, 6, CD011006.
   Google Scholar
• Pahnke, W. N., Kurland, A. A., Goodman, L. E., & Richards, W. A. (1969). LSD-assisted psychotherapy with terminal cancer patients. Current Psychiatric Therapies, 9, 144–152.
   PubMedGoogle Scholar
• Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology, 21, 602–606. doi:10.1200/JCO.2003.07.071
   PubMed Web of Science ®Google Scholar
• Puchalski, C.M. (2012). Spirituality in the cancer trajectory. Annals of Oncology, 23, 49–55. doi:10.1093/annonc/mds088
   PubMed Web of Science ®Google Scholar
• Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majic, T. (2018). Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Progress in Neuropsychopharmacology & Bioilogical Psychiatry, 81, 1–10. doi:10.1016/j.pnpbp.2017.09.012
   PubMed Web of Science ®Google Scholar
• Richards, W. A., Rhead, J. C., DiLeo, F. B., Yensen, R., & Kurland, A. A. (1977). The peak experience variable in DPT-assisted psychotherapy with cancer patients. Journal of Psychedelic Drugs, 9, 1–10. doi:10.1080/02791072.1977.10472020
   Web of Science ®Google Scholar
• Richards, W. A. (1980). Psychedelic drug-assisted psychotherapy with persons suffering from terminal cancer. Journal Altered state of consciousness, 5, 309–319.
   Google Scholar
• Ries, L. A. G., Melbert, D., Krapcho, M., Stinchcomb, D. G., Howlader, N., Horner, M. J., Mariotto, A., Miller, B. A., Feuer, E. J., Altekruse, S., Lewis, D. R., Clegg, L., Eisner, M. P., Reichman, M., Edwards, B. K. (eds.). (2007) SEER cancer statistics review, 1975–2005. Bethesda: National Cancer Institute.
   Google Scholar
• Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30, 1165–1180. doi:10.1177/0269881116675512
   PubMed Web of Science ®Google Scholar
• Saunders, C. (1988). Spiritual pain. Indian Journal of Palliative Care, 4, 29–32.
   Google Scholar
• Storm, H. H., Christensen, N., & Jensen, O. M. (1992). Suicides among Danish patients with cancer: 1971 to 1986. Cancer, 69, 1507–1512.
   PubMed Web of Science ®Google Scholar
• Strassman, R. J., & Qualls, C. R. (1994). Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry, 51, 85–97. doi:10.1001/archpsyc.1994.03950020009001
   PubMed Web of Science ®Google Scholar
• Taylor, E. J. (2003). Spiritual needs of patients with cancer and family caregivers. Cancer Nursing, 26, 260–266. doi:10.1097/00002820-200308000-00002
   PubMed Web of Science ®Google Scholar
• Wasson, R. G. (1957). Seeking the magic mushroom. Life (magazine), 42, 100.
   Google Scholar
• Yousaf, U., Christensen, M. L., Engholm, G., & Storm, H.H. (2005). Suicides among Danish cancer patients 1971-1999. British Journal of Cancer, 92, 995–1000. doi:10.1038/sj.bjc.6602424
   PubMed Web of Science ®Google Scholar
• Zabora, J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001). The prevalence of psychological distress by cancer site. Psychooncology, 10, 19–28.
   PubMed Web of Science ®Google Scholar